# Development Plan: Z-AI Pharmacy Platform (DrugEye)

This document outlines the strategic roadmap for scaling the **DrugEye** platform from its current robust prototype phase to a full-scale clinical-grade production environment.

---

## **1. Project Scope & Objectives**
The **Z-AI Pharmacy Platform** is a clinical decision support system (CDSS) designed to enhance patient safety through AI-powered drug interaction checks, dosage calculations, and comprehensive clinical data management, with a primary focus on the UAE healthcare market.

- **Primary Objectives**:
    - Provide 99.9% accurate drug-drug, drug-disease, and drug-food interaction checks.
    - Automate UAE Ministry of Health (MOH) clinical guideline compliance.
    - Streamline clinical data enrichment for healthcare providers.
    - Offer a seamless, AI-integrated patient consultation experience.

---

## **2. Technical Specifications**
The platform leverages a modern, high-performance stack optimized for data-intensive clinical applications.
- **Frontend**: Next.js 16 (App Router), Tailwind CSS, Framer Motion for animations.
- **Backend/API**: Next.js Server Actions and Route Handlers.
- **Database**: PostgreSQL (via Neon) with Prisma ORM for type-safe database access.
- **AI Engine**: Vercel AI SDK integrating Groq (for speed) and OpenAI (for complex clinical reasoning).
- **Clinical Data**: Multi-source ingestion (FDA, SIDER, UAE MOH, ICD-10) managed via custom ETL pipelines in `database/data-engine/`.
- **Infrastructure**: Vercel for hosting, with edge-optimized middleware for global low-latency access.

---

## **3. Implementation Phases & Milestones**
The development is structured into four distinct phases to ensure stability and clinical accuracy.

| Phase | Milestone | Deliverables |
| :--- | :--- | :--- |
| **Phase 1: Data Consolidation** | **Complete Unified Data Engine** | Standardized drug-to-ICD-10 mappings, enriched side-effect profiles, and MOH alert integration. |
| **Phase 2: Core Features** | **Clinical Utility Parity** | Interaction checker, G6PD safety alerts, pregnancy safety panels, and pediatric dosing calculators. |
| **Phase 3: AI Refinement** | **Clinical AI Integration** | Fully functional AI chat and automated clinical documentation. |
| **Phase 4: Launch & Scale** | **Production Readiness** | Multi-tenant admin dashboard, subscription management, and HIPAA/MOH compliant audit logging. |

---

## **4. Resource Allocation**
- **Core Engineering**: 2 Full-stack developers (Next.js/Prisma), 1 Data Engineer (ETL/NLP).
- **Clinical Quality**: 1 Clinical Pharmacist (Data Validation), 1 Regulatory Consultant (UAE Compliance).
- **Product & Design**: 1 UI/UX Designer, 1 Product Manager.

---

## **5. Quality Assurance & Testing Strategy**
Given the clinical nature of the software, QA is tiered:
- **Unit Testing**: Vitest for utility functions and hooks.
- **Integration Testing**: Testing API routes and database migrations.
- **Clinical Validation**: Manual verification of interaction results by medical professionals against established pharmacopeias.
- **Automated Monitoring**: Performance tracking via `@vercel/analytics` and custom mapping quality scripts.

---

## **6. Deployment & Maintenance Procedures**
- **CI/CD**: GitHub Actions for automated linting, testing, and deployment to Vercel.
- **Database Migrations**: Managed via Prisma with shadow database validation to prevent production downtime.
- **Post-Launch Maintenance**:
    - Weekly drug database updates via automated pipelines.
    - Monthly security audits and clinical guideline reviews.
    - 24/7 system monitoring for API latency and AI model drift.

---

## **7. Risk Management**
- **Data Accuracy Risk**: Mitigated by safety validation logic and clear medical disclaimers.
- **Compliance Risk**: Regular alignment with UAE MOH circulars (automated via alert banners).
- **Performance Risk**: Usage of edge-functions and optimized data structures.

---

## **8. Measurable Success Criteria**
- **Accuracy**: >99.5% match with verified medical databases.
- **Performance**: <200ms API response time for drug searches.
- **Engagement**: >70% weekly active users (WAU) for clinical staff.
- **Safety**: Zero critical clinical errors reported post-launch.

---

## **9. Stakeholder Communication Protocols**
- **Internal**: Weekly sprint reviews and a shared tasklist dashboard.
- **External**: Monthly clinical efficacy reports and transparent changelogs for institutional partners.
